Literature DB >> 16977487

Radiation-induced brain tumours in nevoid basal cell carcinoma syndrome: implications for treatment and surveillance.

Q Choudry1, H C Patel, N T Gurusinghe, D G Evans.   

Abstract

INTRODUCTION: We report two cases of radiation-induced intracranial tumours after treatment for medulloblastoma presenting in children with nevoid basal cell carcinoma syndrome. DISCUSSION: These cases illustrate the need for judicious use of post-operative radiotherapy as secondary tumors are commonly reported. This is particularly important as the initial tumour in this cohort is of the 'less aggressive' desmoplastic subtype.

Entities:  

Mesh：

Year:  2006        PMID： 16977487     DOI： 10.1007/s00381-006-0178-4

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN： 0256-7040            Impact factor:   1.475


  13 in total

1.  Multiple neoplasms following craniospinal irradiation for medulloblastoma in a patient with nevoid basal cell carcinoma syndrome. Case report.

Authors:  S O'Malley; D Weitman; M Olding; L Sekhar
Journal:  J Neurosurg       Date:  1997-02       Impact factor: 5.115

2.  Medulloblastoma with extensive nodularity: a variant with favorable prognosis.

Authors:  F Giangaspero; G Perilongo; M P Fondelli; M Brisigotti; C Carollo; R Burnelli; P C Burger; M L Garrè
Journal:  J Neurosurg       Date:  1999-12       Impact factor: 5.115

3.  Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.

Authors:  R D Kortmann; J Kühl; B Timmermann; U Mittler; C Urban; V Budach; E Richter; N Willich; M Flentje; F Berthold; I Slavc; J Wolff; C Meisner; O Wiestler; N Sörensen; M Warmuth-Metz; M Bamberg
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-01-15       Impact factor: 7.038

4.  Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.

Authors:  P M Zeltzer; J M Boyett; J L Finlay; A L Albright; L B Rorke; J M Milstein; J C Allen; K R Stevens; P Stanley; H Li; J H Wisoff; J R Geyer; P McGuire-Cullen; J A Stehbens; S B Shurin; R J Packer
Journal:  J Clin Oncol       Date:  1999-03       Impact factor: 44.544

Review 5.  Medulloblastoma: signalling a change in treatment.

Authors:  Richard J Gilbertson
Journal:  Lancet Oncol       Date:  2004-04       Impact factor: 41.316

Review 6.  Nevoid basal cell carcinoma syndrome: relation with desmoplastic medulloblastoma in infancy. A population-based study and review of the literature.

Authors:  Seyed F A Amlashi; Laurent Riffaud; Gilles Brassier; Xavier Morandi
Journal:  Cancer       Date:  2003-08-01       Impact factor: 6.860

7.  Brain tumours and the occurrence of severe invasive basal cell carcinoma in first degree relatives with Gorlin syndrome.

Authors:  D G Evans; J M Birch; C I Orton
Journal:  Br J Neurosurg       Date:  1991       Impact factor: 1.596

Review 8.  Late neurocognitive sequelae in survivors of brain tumours in childhood.

Authors:  Raymond K Mulhern; Thomas E Merchant; Amar Gajjar; Wilburn E Reddick; Larry E Kun
Journal:  Lancet Oncol       Date:  2004-07       Impact factor: 41.316

9.  The gene for the naevoid basal cell carcinoma syndrome acts as a tumour-suppressor gene in medulloblastoma.

Authors:  R Cowan; P Hoban; A Kelsey; J M Birch; R Gattamaneni; D G Evans
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 10.  The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma.

Authors:  D G Evans; P A Farndon; L D Burnell; H R Gattamaneni; J M Birch
Journal:  Br J Cancer       Date:  1991-11       Impact factor: 7.640
View more
  7 in total

1.  Syndromes predisposing to pediatric central nervous system tumors: lessons learned and new promises.

Authors:  Anita Villani; David Malkin; Uri Tabori
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

2.  Deficient expression of aldehyde dehydrogenase 1A1 is consistent with increased sensitivity of Gorlin syndrome patients to radiation carcinogenesis.

Authors:  Aaron T Wright; Thierry Magnaldo; Ryan L Sontag; Lindsey N Anderson; Natalie C Sadler; Paul D Piehowski; Yannick Gache; Thomas J Weber
Journal:  Mol Carcinog       Date:  2013-11-27       Impact factor: 4.784

Review 3.  Nevoid basal cell carcinoma syndrome (Gorlin syndrome).

Authors:  Lorenzo Lo Muzio
Journal:  Orphanet J Rare Dis       Date:  2008-11-25       Impact factor: 4.123

4.  Neuroimaging of nevoid basal cell carcinoma syndrome (NBCCS) in children.

Authors:  Kamyar Sartip; Adam Kaplan; George Obeid; Nadja Kadom
Journal:  Pediatr Radiol       Date:  2012-11-14

5.  Novel SUFU Frameshift Variant Leading to Meningioma in Three Generations in a Family with Gorlin Syndrome.

Authors:  Gustav Askaner; Ulrikke Lei; Birgitte Bertelsen; Alessandro Venzo; Karin Wadt
Journal:  Case Rep Genet       Date:  2019-07-28

6.  PTCH1 mutant small cell glioblastoma in a patient with Gorlin syndrome: A case report.

Authors:  John T Dorsey; Ryan T Mott; Christopher M Lack; Nicholas Britt; Shakti H Ramkissoon; Bonny B Morris; Annette Carter; Alisha T Detroye; Michael Chan; Stephen Tatter; Glenn J Lesser
Journal:  Oncol Lett       Date:  2022-07-27       Impact factor: 3.111

Review 7.  Genetic syndromes predisposing to pediatric brain tumors.

Authors:  Sameer Farouk Sait; Michael F Walsh; Matthias A Karajannis
Journal:  Neurooncol Pract       Date:  2021-02-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.